Stockholm - Free Realtime Quote SEK

Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)

2.1500
+0.1000
+(4.88%)
As of 1:28:21 PM GMT+2. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Stefan Mohan Frick Founder, CEO, President & Director -- -- 1974
Ann Ohlsson Head of Finance -- -- 1966

Scandinavian ChemoTech AB (publ)

Medicon Village
Scheeletorget 1
Lund, 223 63
Sweden
46 1 02 18 93 00 https://chemotech.se
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
4

Description

Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.

Corporate Governance

Scandinavian ChemoTech AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events